Published in Adv Exp Med Biol on January 01, 2007
Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol Cell Proteomics (2009) 1.13
Quantitative analysis of a panel of gene expression in prostate cancer--with emphasis on NPY expression analysis. J Zhejiang Univ Sci B (2007) 0.87
Effect of chronic restraint stress on human colorectal carcinoma growth in mice. PLoS One (2013) 0.83
An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer. MAGMA (2008) 0.82
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion. Am J Physiol Cell Physiol (2011) 0.81
Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms. Am J Physiol Gastrointest Liver Physiol (2013) 0.77
Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology. Neuropeptides (2015) 0.75
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Am J Pathol (2016) 0.75
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res (2004) 2.47
Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke (2007) 2.04
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol (2011) 1.56
Temporal data mining for the quality assessment of hemodialysis services. Artif Intell Med (2005) 1.27
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res (2005) 1.19
Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab (2011) 1.10
VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development (2011) 1.03
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release. J Biol Eng (2011) 1.02
The use of benthic indicators in Europe: from the Water Framework Directive to the Marine Strategy Framework Directive. Mar Pollut Bull (2010) 1.01
Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer Res (2008) 1.01
Characterization of an inducible promoter in different DNA copy number conditions. BMC Bioinformatics (2012) 1.01
Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr (2008) 1.01
The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol (2012) 1.00
The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol (2003) 1.00
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. BMC Bioinformatics (2006) 0.98
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices. PLoS One (2012) 0.98
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling. Int J Oncol (2006) 0.97
Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol (2013) 0.96
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) (2005) 0.96
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Endocrinology (2005) 0.95
Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res (2010) 0.95
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. Endocrinology (2011) 0.92
Modeling of human tumor xenografts and dose rationale in oncology. Drug Discov Today Technol (2013) 0.91
TA-clustering: cluster analysis of gene expression profiles through Temporal Abstractions. Int J Med Inform (2005) 0.90
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli. J Biol Eng (2013) 0.89
Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physiol Endocrinol Metab (2002) 0.89
Feeding behavior in mammals including humans. Ann N Y Acad Sci (2009) 0.88
Multiplexing and demultiplexing logic functions for computing signal processing tasks in synthetic biology. Biotechnol J (2011) 0.87
GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies. Endocr Rev (2012) 0.87
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways. Cancer Lett (2009) 0.86
The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. Eur J Pharmacol (2010) 0.86
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts. Cancer Chemother Pharmacol (2013) 0.86
Precedence Temporal Networks to represent temporal relationships in gene expression data. J Biomed Inform (2007) 0.86
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. Endocr Relat Cancer (2013) 0.85
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. BMC Evol Biol (2011) 0.84
Schwann-like adult stem cells derived from bone marrow and adipose tissue express γ-aminobutyric acid type B receptors. J Neurosci Res (2011) 0.84
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase. Int J Cancer (2004) 0.83
A Perl procedure for protein identification by Peptide Mass Fingerprinting. BMC Bioinformatics (2009) 0.83
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells. Int J Oncol (2004) 0.82
GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int J Pharm (2012) 0.82
Random walk models for bayesian clustering of gene expression profiles. Appl Bioinformatics (2005) 0.82
Comprehensive two-dimensional gas chromatography using large sample volume injection for the determination of polynuclear aromatic hydrocarbons in complex matrices. J Chromatogr A (2003) 0.82
Association with meteo-climatological factors and daily emergency visits for renal colic and urinary calculi in Cuneo, Italy. A retrospective observational study, 2007-2010. Int J Biometeorol (2014) 0.82
Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-α and NF-κB nuclear translocation in BV-2 microglia. Phytother Res (2012) 0.82
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination. Cancer Chemother Pharmacol (2013) 0.82
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response. Ther Drug Monit (2002) 0.81
Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. J Cell Physiol (2012) 0.81
A model-based approach to the in vitro evaluation of anticancer activity. Cancer Chemother Pharmacol (2008) 0.81
Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells. J Clin Endocrinol Metab (2009) 0.81
Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib. Prostate (2011) 0.81
Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Br J Nutr (2012) 0.81
Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort. Obes Facts (2012) 0.80
Adipokine actions on cartilage homeostasis. Adv Clin Chem (2011) 0.80
Modelling the effects of cell-to-cell variability on the output of interconnected gene networks in bacterial populations. BMC Syst Biol (2015) 0.80
Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve (2012) 0.80
Inferring gene regulatory networks by integrating static and dynamic data. Int J Med Inform (2007) 0.80
Altered peripheral myelination in mice lacking GABAB receptors. Mol Cell Neurosci (2007) 0.80
Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. Neuro Endocrinol Lett (2006) 0.80
On the myths of indicator species: issues and further consideration in the use of static concepts for ecological applications. PLoS One (2013) 0.80
Adiponectin interactions in bone and cartilage biology and disease. Vitam Horm (2012) 0.80
The synthesis of glycoprotein Po and peripheral myelin protein 22 in sciatic nerve of male rats is modulated by testosterone metabolites. Brain Res Mol Brain Res (2004) 0.80
TGI-Simulator: a visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug. Comput Methods Programs Biomed (2011) 0.79
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies. BMC Bioinformatics (2010) 0.79
Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer. Peptides (2007) 0.79
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor. Oncol Res (2003) 0.78
Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells. Oncol Rep (2002) 0.78
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time. Cancer Chemother Pharmacol (2003) 0.78
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study. Int J Endocrinol (2011) 0.78
Integrating model-based decision support in a multi-modal reasoning system for managing type 1 diabetic patients. Artif Intell Med (2003) 0.78
Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Aging Male (2013) 0.77
Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases. Clin Chem Lab Med (2016) 0.77
Comment on: Adipokines, hormonal parameters, and cardiovascular risk factors: similarities and differences between patients with erectile dysfunction of arteriogenic and nonarteriogenic origin. J Sex Med (2012) 0.77
BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis. Neurodegener Dis (2016) 0.76
Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis. Immun Ageing (2013) 0.76
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance. Eur J Clin Invest (2014) 0.76
SRC-1 is involved in the control of the gene expression of myelin protein Po. J Mol Neurosci (2004) 0.76
Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells. Peptides (2007) 0.76
Natural zeolites chabazite/phillipsite/analcime increase blood levels of antioxidant enzymes. J Clin Biochem Nutr (2011) 0.75
Regulation of prostate cancer cell proliferation by somatostatin receptor activation. Mol Cell Endocrinol (2009) 0.75
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Aldosterone receptor antagonists: biology and novel therapeutic applications. Curr Hypertens Rep (2005) 0.75
In memoriam. Professor Antonio Liuzzi (1939-2013). J Endocrinol Invest (2013) 0.75
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor. Bioconjug Chem (2016) 0.75
Italian air force acrobatic pilots are protected against flight-induced oxidative stress. In Vivo (2011) 0.75
Total, free and bound leptin and thyroid function in elderly women with different body weights. Clin Endocrinol (Oxf) (2007) 0.75